News
$IGC - IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
Nov 18, 2026 · ThinkSabio Blog
$IGC - IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
18-NOV-2026 08:00 AM ET
Share this post
💬 Comments
Loading comments…
Leave a comment
